Toe dystonia in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation

J Neurol Sci. 2018 Sep 15:392:65-68. doi: 10.1016/j.jns.2018.07.004. Epub 2018 Jul 12.

Abstract

Background: Off state toe dystonia (TD) is a symptom frequently encountered in Parkinson's disease (PD), but little is known about its evolution after subthalamic nucleus deep brain stimulation (STN-DBS).

Objective: To analyze the prevalence and the evolution of TD in PD patients candidate to STN-DBS.

Methods: Individual data of consecutive 130 PD patients who underwent STN-DBS between 2010 and 2015 were collected.

Results: Data were successfully collected in 95 patients. TD affect 45.3% of the patients in our cohort. TD was present in 32.7% of patients before surgery and was alleviated by STN-DBS in 48% of the cases. Motor improvement provided by STN-DBS, levodopa-equivalent treatment diminution after surgery, disease duration or age at the time of surgery were not predictive of TD evolution. A younger age at PD diagnosis was significantly associated with TD resolution.

Conclusion: STN-DBS is partially efficient for TD but its evolution seems independent of significant predictive factors.

Keywords: Deep brain stimulation; Levodopa induced dyskinesia; Parkinson's disease; Subthalamic nucleus; Toe dystonia.

MeSH terms

  • Adult
  • Deep Brain Stimulation / methods*
  • Dystonia / etiology*
  • Dystonia / therapy*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Parkinson Disease / complications*
  • Retrospective Studies
  • Subthalamic Nucleus / physiology*
  • Toes / physiopathology*
  • Treatment Outcome
  • Young Adult